Volume 34, Issue 2 pp. 236-239

Effects of antikeratin 16 antibodies on the expression of Toll-like receptors 2 and 4 in keratinocytes

C. Wu

C. Wu

Department of Dermatology, Huashan Hospital, Medical College, Fudan University, Shanghai, China

Shaanxi Hospital of Traditional Chinese Medicine, Xi’an, China

Search for more papers by this author
Q. Luan

Q. Luan

Department of Dermatology, Huashan Hospital, Medical College, Fudan University, Shanghai, China

Search for more papers by this author
C. Li

C. Li

Shaanxi Hospital of Traditional Chinese Medicine, Xi’an, China

Dermatology Center, Chinese PLA, Xijing Hospital, Fourth Military Medical University, Xi’an, China

Search for more papers by this author
Z. Zheng

Z. Zheng

Department of Dermatology, Huashan Hospital, Medical College, Fudan University, Shanghai, China

Dermatology Center, Chinese PLA, Xijing Hospital, Fourth Military Medical University, Xi’an, China

Search for more papers by this author
First published: 21 January 2009
Citations: 8

Professor Zhizhong Zheng, Department of Dermatology of Huashan Hospital, Medical College of Fudan University, 12 WuLuMuQi Zhong Road, Shanghai 200040, China.
E-mail: [email protected]

Professor Chenxin Li, Dermatology Center of Chinese PLA, Xijing Hospital, Fourth Military Medical University, Xi’an 710032, China.
E-mail: [email protected].

Conflict of interest: none declared.

Summary

Innate immunity plays an important role in psoriasis. The possible role of Toll-like receptors (TLRs) in the activation of innate immunity in psoriasis remains unknown. Serum antikeratin 16 (anti-K16) autoantibody levels are raised in patients with psoriasis. The aim of this study was to investigate the effects of anti-K16 antibodies on TLR2 and TLR4 expression in keratinocytes. Keratinocytes were incubated with mouse anti-K16 monoclonal antibodies. Levels of TLR2 and TLR4 were measured by quantitative real-time PCR and flow cytometry. TLR2 mRNA level was increased by 1.73-fold, 1.60-fold and 2.52-fold at 6, 24 and 36 h after incubation, respectively. TLR4 mRNA level was increased by 3.62-fold and 2.21-fold at 12 and 36 h, respectively. TLR2 protein expression was increased by 1.73-fold on the cell membrane and 2.22-fold in cell membrane and intracytoplasmic locations. There was no change in TLR4. The results of this study indicate that anti-K16 antibodies may be a modulator of TLRs.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.